JF
MGNX icon

Jump Financial’s MacroGenics MGNX Stock Holding History

Jump Financial’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,534
Closed -$14K – 2037
2025
Q2 		$14K Buy
+11,534
New +$16.7K ﹤0.01% 1730
2025
Q1 		– Sell
-13,600
Closed -$44.2K – 1852
2024
Q4 		$44.2K Buy
+13,600
New +$49K ﹤0.01% 1570
2024
Q1 		– Sell
-14,060
Closed -$135K – 2135
2023
Q4 		$135K Buy
+14,060
New +$97.2K ﹤0.01% 1628
2023
Q2 		– Sell
-95,200
Closed -$683K – 2020
2023
Q1 		$683K Buy
95,200
+45,312
+91% +$273K 0.03% 762
2022
Q4 		$335K Buy
49,888
+4,288
+9% +$23.5K 0.02% 977
2022
Q3 		$158K Sell
45,600
-13,200
-22% -$50.5K 0.01% 1389
2022
Q2 		$173K Buy
58,800
+7,800
+15% +$41K 0.01% 1342
2022
Q1 		$449K Buy
51,000
+15,865
+45% +$175K 0.02% 864
2021
Q4 		$563K Buy
+35,135
New +$661K 0.04% 599
2021
Q2 		– Sell
-8,171
Closed -$260K – 1282
2021
Q1 		$260K Buy
+8,171
New +$198K 0.02% 660

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Financial's MGNX Position: Q3 2025 in Review

Jump Financial sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 11,534 shares — an estimated $14K sold.

Jump Financial first reported a position in MGNX in Q1 2021 and held it in 10 quarters. The position peaked at $683K in Q1 2023. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

  • Jump Financial reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 11,534 MacroGenics shares in Q3 2025, an estimated $14K.
  • Jump Financial first reported a position in MacroGenics in Q1 2021 and held it in 10 quarters.
  • Jump Financial's MacroGenics position peaked at $683K in Q1 2023.
  • 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.